Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,857,760
  • Shares Outstanding, K 142,386
  • Annual Sales, $ 267,590 K
  • Annual Income, $ 129,090 K
  • 60-Month Beta 1.47
  • Price/Sales 22.44
  • Price/Cash Flow 38.69
  • Price/Book 90.93
Trade HALO with:

Options Overview

Details
  • Implied Volatility 66.03%
  • Historical Volatility 23.35%
  • IV Percentile 95%
  • IV Rank 76.15%
  • IV High 74.70% on 03/05/21
  • IV Low 38.34% on 07/27/21
  • Put/Call Vol Ratio 0.03
  • Today's Volume 146
  • Volume Avg (30-Day) 292
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 12,612
  • Open Int (30-Day) 14,176

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 0.43
  • Number of Estimates 4
  • High Estimate 0.65
  • Low Estimate 0.32
  • Prior Year 0.19
  • Growth Rate Est. (year over year) +126.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.95 +4.15%
on 07/19/21
46.62 -10.75%
on 07/02/21
-4.35 (-9.46%)
since 06/28/21
3-Month
38.65 +7.66%
on 06/03/21
51.57 -19.31%
on 04/29/21
-9.41 (-18.44%)
since 04/28/21
52-Week
25.17 +65.32%
on 09/24/20
56.40 -26.22%
on 02/24/21
+14.44 (+53.15%)
since 07/28/20

Most Recent Stories

More News
Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2021 on at / . Dr. , president and chief executive officer, will lead...

HALO : 41.61 (+1.14%)
/C O R R E C T I O N from Source -- Halo Collective Inc./

In the news release "Halo Collective Plans To Acquire William's Wonder Farms " issued 24-Jul-2021 by Halo Collective Inc. over CNW, the company advises that the content has been updated. The complete,...

HALO : 41.61 (+1.14%)
HCANF : 0.0340 (+3.66%)
Halo Collective Plans to Acquire William's Wonder Farms

/Not for Distribution to U.S. Newswire Services or For Dissemination in the United States/

HALO : 41.61 (+1.14%)
HCANF : 0.0340 (+3.66%)
Halo Collective Awarded Large White Label Contract by Papa's Herb�, a Leading California Brand

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

HALO : 41.61 (+1.14%)
HCANF : 0.0340 (+3.66%)
Halo Collective Completes Securities Issuance to Independent Consultants, Related Parties, and Suppliers

COMTEX_390134745/2669/2021-07-20T16:15:20

HALO : 41.61 (+1.14%)
HCANF : 0.0340 (+3.66%)
Papa's Herb® Enters the Oregon Market Through Halo Collective

COMTEX_390047821/2669/2021-07-19T10:52:15

HALO : 41.61 (+1.14%)
HCANF : 0.0340 (+3.66%)
TLRY : 16.01 (+25.77%)
/R E P E A T -- Halo Collective Announces Purchase of KushBar Retail Assets from High Tide/

COMTEX_389855938/2669/2021-07-15T09:00:54

HALO : 41.61 (+1.14%)
HCANF : 0.0340 (+3.66%)
HITI.VN : 7.760 (+4.86%)
HITI : 6.13 (+4.43%)
TLRY.TO : 20.05 (+25.08%)
TLRY : 16.01 (+25.77%)
ACB.TO : 9.15 (+6.52%)
ACB : 7.29 (+6.58%)
Halo Collective Announces Purchase of KushBar Retail Assets from High Tide

COMTEX_389839647/2669/2021-07-15T03:00:32

HALO : 41.61 (+1.14%)
HCANF : 0.0340 (+3.66%)
HITI.VN : 7.760 (+4.86%)
HITI : 6.13 (+4.43%)
TLRY.TO : 20.05 (+25.08%)
TLRY : 16.01 (+25.77%)
ACB.TO : 9.15 (+6.52%)
ACB : 7.29 (+6.58%)
TFF Pharmaceuticals (TFFP) Completes Enrollment in Phase I Study

TFF Pharmaceuticals (TFFP) completes enrollment in the phase I study on tacrolimus inhalation powder and announces positive preliminary data.

BAYRY : 14.8900 (-0.20%)
HALO : 41.61 (+1.14%)
ZTS : 203.27 (+0.69%)
TFFP : 8.65 (+2.37%)
Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse

/PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Janssen Biotech, Inc. (Janssen) received U.S. Food and Drug Administration (FDA) approval of DARZALEX FASPRO (daratumumab...

HALO : 41.61 (+1.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The company's broad product development portfolio, including expected...

See More

Key Turning Points

3rd Resistance Point 43.59
2nd Resistance Point 42.86
1st Resistance Point 42.23
Last Price 41.61
1st Support Level 40.87
2nd Support Level 40.14
3rd Support Level 39.51

See More

52-Week High 56.40
Fibonacci 61.8% 44.47
Last Price 41.61
Fibonacci 50% 40.78
Fibonacci 38.2% 37.10
52-Week Low 25.17

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar